Atlas Trials

Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory Cancer

Clinical trial NCT00547261 · TERMINATED

Trial details

NCT number
NCT00547261
Sponsor
Sanofi
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms
Start date
2007-10-01
Primary completion
2008-08-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.